Evidence map›Paper›PMID 40033397›Full record

Trial reportHealth and quality of life outcomes2025

Reliability of the electronic patient reported outcome measures for assessing xerostomia, dysphagia and quality of life in Spanish patients with head and neck cancer: a randomised crossover design.

Mario Lozano-Lozano, Maria Lopez-Garzon, Paula Cuadrado-Guerrero, Paula Postigo-Martin, Carolina Fernández-Lao, Isabel Tovar-Martín, Noelia Galiano-Castillo

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Health and quality of life outcomes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05106608 (Photobiomodulation Therapy With M-health Tool for the Management of Oral Health and Quality of Life in Head and Neck Cancer Patients), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05106608 narecruitingnot on this map

Photobiomodulation Therapy With M-health Tool for the Management of Oral Health and Quality of Life in Head and Neck Cancer Patients: LAXER Study

TypeinterventionalSponsorUniversidad de GranadaRan2022 to 2026Enrolled60ConditionsHead and Neck Cancer, Head and Neck Neoplasms, XerostomiaArmsEnergy density photobiomodulation (7.5), Energy density photobiomodulation (3), Sham placebo
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mario Lozano-LozanoBiomedical Group (BIO277), Department of Physical Therapy, Health Sciences Faculty, University of Granada, Granada, Spain.ORCID http://orcid.org/0000-0001-5854-3567
Maria Lopez-GarzonBiomedical Group (BIO277), Department of Physical Therapy, Health Sciences Faculty, University of Granada, Granada, Spain. maloga@ugr.es.ORCID http://orcid.org/0000-0002-9229-9673
Paula Cuadrado-GuerreroDepartment of Radiation Oncology, Hospital HLA Inmaculada, Granada, Spain.
Paula Postigo-MartinBiomedical Group (BIO277), Department of Physical Therapy, Health Sciences Faculty, University of Granada, Granada, Spain.ORCID http://orcid.org/0000-0001-6430-5207
Carolina Fernández-LaoBiomedical Group (BIO277), Department of Physical Therapy, Health Sciences Faculty, University of Granada, Granada, Spain.ORCID http://orcid.org/0000-0002-9392-1532
Isabel Tovar-MartínInstituto de Investigación Biosanitaria, Ibs.GRANADA, Granada, Spain.
Noelia Galiano-CastilloBiomedical Group (BIO277), Department of Physical Therapy, Health Sciences Faculty, University of Granada, Granada, Spain.ORCID http://orcid.org/0000-0002-6825-4213

Funding

Consejería de Salud, Junta de Andalucia PI-0187-2021European Regional Development Fund ERDF-FEDER
6 · The paper itself

Abstract

purposeTo analyse reliability in terms of concordance (agreement) and equivalence of the Patient Reported Outcome Measures (PROM) with an electronic modality (ePROM) of the recognised questionnaires assessing of xerostomia, dysphagia and quality of life (QoL) in Spanish patients with head and neck cancer (HNC). We hypothesised notable reliability and equivalence between the two modalities.

methodsA total of 24 patients (median age 63.00 years, undergone radiotherapy, either alone or in combination with surgery and/or chemotherapy, and suffering xerostomia) were randomised to either paper-based (PROM) or ePROM in a two-arm crossover design with a within-subject comparison of the two modalities (washout period 90 min). Outcome measures of interest were xerostomia: severity itself (Xerostomia Inventory, XI), perceived xerostomia (visual analogue scale, VAS), regional oral dryness (Regional Oral Dryness Inventory, RODI) and dry mouth/sticky saliva (specific head and neck module European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Head and Neck Module, EORTC QLQ-H&N35 and updated EORTC QLQ-H&N43); dysphagia: swallowing burden (Eating Assessment Tool-10, EAT-10) and swallowing (EORTC QLQ-H&N35 and EORTC QLQ-H&N43); and QoL: global health (EORTC QLQ-Core 30, EORTC QLQ-C30). Data concerning the concordance between modalities was evaluated using Spearman correlation coefficients, intraclass correlation coefficients (ICCs) and Bland Altman plots with limits of agreement. In addition, a two one-sided test to check equivalence with clinical importance changes. Finally, 1-week time span separated test and retest of ePROM (only electronic modality) using Wilcoxon test and ICCs.

resultsThere was excellent concordance (PROM versus ePROM 0.79-0.96) with most differences fell within the limits of agreement. The equivalence analysis showed that the difference between both modalities was not more than a tolerably small amount (P < 0.05), except for dysphagia and QoL. Analysis over time exhibited from good to excellent (0.81-0.93) test-retest stability for the majority of outcome measures.

conclusionThe newly developed ePROMs embedded into LAXER application have showed high level of reliability that supports their implementation in clinical practice, offering a convenient and efficient alternative to paper-based questionnaires. This study shows that electronic adaptations are possible despite the challenging older target population.

trial registrationThe study is part of the LAXER study (2021-11-04 / ClinicalTrials.gov: NCT05106608).

Indexed as

Deglutition DisordersHead and Neck NeoplasmsPatient Reported Outcome MeasuresQuality of LifeXerostomiaAdultAgedCross-Over StudiesFemaleHumansMaleMiddle AgedReproducibility of ResultsSpainSurveys and QuestionnairesDeglutition DisordersElectronic Health RecordsHead and Neck NeoplasmsPatient Reported Outcome MeasuresQuality of LifeXerostomia

Identifiers

PMID40033397
PMCPMC11877701

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.